The newly published report by IMARC Group, titled ”Pertussis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the pertussis market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
What is pertussis market?
Pertussis is an infectious disease that occurs due to bacteria, primarily impacts the respiratory system, and can affect people of all ages, although it is most prevalent in infants and young children. The infection is highly transmissible, spreading through respiratory droplets from coughs or sneezes, especially in the initial two weeks of the illness. Notable symptoms include a severe cough, often accompanied by a distinctive “whoop” sound. Other symptoms can encompass nasal congestion, sneezing, mild fever, vomiting, breathing difficulty, fatigue, and watery eyes, among others. A combination of clinical examination, history assessment, and specific tests helps diagnose the disease. Lab investigations involve nasopharyngeal swabs or aspirates analyzed through PCR or culture techniques to detect bacteria or their genetic material. Occasionally, a chest X-ray may be conducted to evaluate lung function and exclude other potential respiratory conditions.
Request a Sample Report : https://www.imarcgroup.com/pertussis-market/requestsample
What are the key drivers and trends in the pertussis market?
The pertussis market is seeing considerable growth, driven primarily by a rise in bacterial infectious diseases transmitted via respiratory droplets. This is compounded by the increasing incidents of insufficient vaccination against the disease, heightening infection risk. The market’s growth is further fueled by the widespread use of potent antibiotics, including azithromycin, clarithromycin, erythromycin, etc., that curb the disease’s duration and prevent its spread.
Also contributing to the market expansion is the growing use of saline nasal drops, which alleviate discomfort by hydrating irritated tissues. Additionally, intravenous (IV) fluid therapy is gaining traction among patients experiencing respiratory distress or feeding difficulty, as it ensures efficient delivery and helps to maintain proper electrolyte balance. This trend is expected to further propel the pertussis market in the projected period.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the pertussis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the pertussis market Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/pertussis-market
Key Questions Answered in this Report:
- How has the pertussis market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the pertussis market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the pertussis market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Significant Benefits of the Report to Stakeholders:
- Individuals directly or indirectly involved in the value chain of the pertussis market can gain valuable insights into key players and major market trends, enabling them to stay up-to-date and make informed decisions.
- Professionals responsible for selecting a pertussis market for large and enterprise-level organizations can conduct thorough due diligence by leveraging the comprehensive information provided in this report.
- Those seeking current intelligence on the dynamic pertussis market can benefit from the report’s valuable insights, helping them stay informed and make strategic business decisions.
- Companies operating in the pertussis market can benchmark and assess their market position and standing against their competitors, gaining a strategic viewpoint to evaluate and adapt to the changing market landscape.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800